Li Tang is an Associate Professor of Bioengineering, and Vice Dean for Innovation at School of Life Sciences, École polytechnique fédérale de Lausanne (EPFL), Switzerland. He is also co-founder & chair of Leman Biotech. His research focuses on developing multidimensional immunoengineering approaches for enhanced cancer immunotherapies with some being tested in the clinic currently. Dr. Tang is the recipient of Lem Prize (2025), Highly Cited Researcher Award (2025), Friedrich Miescher Award (2025), Leenaards Prize for Translational Medical Research (2025), Biomaterials Science Lectureship (2025), CAB Mid-Career Investigator Award (2024), Biomaterials Award for Young Investigators (2024), Cancer Research Institute CLIP Award (2021), Anna Fuller Award (2021 and 2022), European Research Council (ERC) Starting Grant Award (2018), and named in the MIT Technology Review’s "Top 35 Innovators under Age 35" list of China region (2020).
